OS Therapies Incorporated
AMEX:OSTX · New York Stock Exchange American
+$0.10 today
Vol 1.14M · Avg 0.71M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+13.53%
Period High
$2.50
Period Low
$1.16
Latest
$1.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Adagene Inc.
NASDAQ:ADAG
$138.36M
Equillium, Inc.
NASDAQ:EQ
$107.81M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$70.24M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$69.75M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$64.11M
MiNK Therapeutics, Inc.
NASDAQ:INKT
$59.11M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
CervoMed Inc.
CRVO
$37.87M
Werewolf Therapeutics, Inc.
HOWL
$17.18M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest OSTX filing?
The latest filing shown is 10-Q dated May 18, 2026.
How many recent filings does OSTX have?
Intrinsic Alpha currently shows 20 recent filings for OSTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.